Medication-Assisted Treatment (MAT)

Proven Opioid Treatment Program

Opioid use disorder can be addressed through medication-assisted treatment: a proven evidence-based practice that forms the foundation of our Safe Start Program.

What is Medication-Assisted Treatment at Cumberland Heights?

When a person becomes reliant on opioid medications like oxycodone (OxyContin) or hydrocodone (Vicodin), their brain operates differently. It becomes accustomed to an artificial supply of certain neurotransmitters and stops producing them on its own. Medication-assisted treatment, or MAT, is the administration of medicine to restore the brain’s chemical balance.

Cumberland Heights’ MAT program is called Safe Start. We use FDA-approved medications like naltrexone and buprenorphine as the basis of our programming, for those with opioid use disorder. These substances do not “replace one addiction with another”—they empower clients to break the cycle of addiction, participate in programming and remain abstinent for years to come. Each person in our MAT program gains access to complementary therapies like cognitive-behavioral therapy and 12-step facilitation. Together, these modalities create a clear path to recovery.

Proven Opioid Treatment Program

Cumberland Heights takes a nationally recognized approach to the treatment of opioid use disorder. Our methods have received accreditation from The Joint Commission, certification from the American Society of Addiction Medicine, and distinctions from organizations like NAATP, Aetna, and BlueCross BlueShield.


Each year, our Research Institute compiles all data about our clients’ treatment results into a robust Outcomes Report. This document details the effectiveness of our modalities in reducing cravings, depression symptoms, anxiety symptoms, and more. To date, we have found that our interventions—including medication-assisted treatment—contributed to:

This data reinforces our status as one of Tennessee’s premier treatment centers for opioid use disorder.

Call Admissions Today

As a preeminent leader in clinically excellent, evidence-based practices and recovery success stories, Cumberland Heights is also Tennessee’s first ASAM-accredited treatment program. Our team of experienced addiction professionals will tailor a plan for your needs.
Call Us

You're taking the first step on your path to recovery. Reach out to us today by phone or by submitting the form below to initiate the admission process. Our team is available to answer your questions & provide the support you need to get started.

Confidential Assessment

Speak with our admissions team and complete a confidential assessment to discuss your needs and challenges. This step helps us determine the most appropriate level of care and treatment options.​

Schedule Your Admission

We ensure transparency and support from the start. After setting a treatment plan, we will schedule your admission, clarify any financial responsibilities, and help you find the right care - no matter who it's with.









Medication-Assisted Treatment: What You Should Know

Opioid addiction significantly changes the brain. If a person has become dependent on these drugs, they may experience severe cravings and withdrawal symptoms upon sudden cessation of opioids. Those who participate in medication-assisted treatment are able to manage their symptoms while gradually recovering from opioid use disorder. Read today’s blog post for more information about MAT.

About Opioid Addiction

Many people first use opioids when they are recovering from a surgical procedure. For example, teens whose wisdom teeth are removed are typically prescribed these medications. Other common opioid drugs include hydrocodone (Vicodin), oxycodone (Percocet/OxyContin), fentanyl, morphine and codeine. However, while these medications may relieve pain, they carry a significant potential for addiction.

Individuals who discover the pain-relieving effects or euphoria associated with opioids can begin to misuse their prescriptions. Eventually, some seek a cheaper alternative in the form of heroin. The physical changes caused by these drugs result in strong cravings and compulsive, continued use – even if someone sincerely wants to stop using. That’s when medication-assisted treatment becomes an especially effective path to recovery.

Medication-Assisted Treatment with Naltrexone and Buprenorphine

The aim of medication-assisted treatment is to help a patient to gradually taper off of opioids while avoiding painful, uncomfortable and potentially life-threatening withdrawal symptoms. Opioid drugs themselves block pain, slow a person’s respiration, calm the user and trigger pain receptors.

These drugs also create abnormalities in the brain’s dopamine production, resulting in a feeling of euphoria. People who enjoy this feeling may begin using over and over again to achieve the same rush. However, this is not without consequence. Over time, continued opioid use leads to changes in the way the brain communicates with the body.

Short-term side effects of opioid use include fatigue, euphoria, nausea and numbness. In the long term, individuals may experience anxiety, depression, hypoxia, hyperalgesia and hallucinations. Areas of the brain impacted by long-term opioid use include the portions responsible for long-term memory, thought processes, social behaviors and decision-making.

Medications like naltrexone and buprenorphine interact with the brain’s opioid receptors. Unlike prescription painkillers or heroin, the drugs used in MAT do not create the euphoric sensations associated with substance use. When taken as directed, buprenorphine and naltrexone fulfill the body’s opioid cravings, all without harmful drug-seeking behavior, euphoria or its associated difficulties.

Put simply, medication-assisted treatment works because it:

  • Relieves physical and psychological cravings
  • Normalizes a person’s brain chemistry
  • Improves functioning
  • Blocks the euphoric effects of opioids
  • Allows the body to return to stasis
  • Addresses withdrawal symptoms
  • Blocks the sedative effects of opioids

Research shows that medication-assisted treatment improves patient outcomes, increases treatment retention and boosts a person’s ability to maintain employment.

It is important to note that MAT is just one tool in a treatment center’s toolbox. We believe that opioid use disorder is best treated holistically. At Cumberland Heights, we couple medication-assisted treatment with rigorous clinical programming and 12-Step work.

Myths About MAT

Unfortunately, this treatment approach is heavily stigmatized, even within the recovery community. It is important to separate fact from fiction when seeking help for an opioid addiction.

Some people view medication-assisted treatment as simply replacing one addictive drug with another. This is not the case. At Cumberland Heights, we have found through our Safe Start Program that naltrexone and buprenorphine are especially effective to patients affected by moderate to severe opioid use disorder. Over time, a treatment provider can adjust a person’s dosage to taper off of these substances.

Other harmful myths about MAT are that it increases overdose risk (proven false by the National Institutes of Health), that it disrupts “true” recovery (a claim that misunderstands recovery as a concept) and that stopping on your own is equally viable (it is much more difficult to cease opioid use on one’s own).

If you are curious about medication-assisted treatment, we encourage you to speak with your primary care physician or another trusted healthcare professional. They can refer you to the appropriate level of care for your substance use disorder.

CDC Planning to Study Medication-Assisted Treatment

In the winter of 2017, the CDC’s National Center for Injury Prevention and Control announced an intention to study medication-assisted treatment. Their research seeks to examine the ways in which patient outcomes vary across the three main medications used for MAT. These outcomes will be compared to those who have received counseling alone.

The CDC hopes that this study will answer questions about the effectiveness of buprenorphine, methadone and naltrexone, as well as medication-free interventions. They will also assess patient characteristics and program factors which may have some bearing on patient outcomes.

Recruitment and enrollment began soon after their announcement, and this summer, the CDC will unveil their findings. Patients from all over the United States will be included among those surveyed – while Tennessee is not on the list, our neighbors in Kentucky, West Virginia and other states with proven opioid epidemics will be studied. Cumberland Heights is hopeful that we will gain some important information about the effectiveness of certain treatments for opioid use disorder.

MAT in Tennessee

If you are struggling with opioid use disorder, or know someone who is, help is here. The team at Cumberland Heights understands how difficult it can be to overcome addiction on your own. That’s why we provide clinically advanced care to people throughout the state of Tennessee. To learn more about medication-assisted treatment through Cumberland Heights, contact our admissions team today.

Scroll to Top